Psychedelics earnings

Psychedelics biotech company Enveric Biosciences (NASDAQ:ENVB) provided a corporate update and reported financial results for the third quarter ended Sept. 30, 2024. "The third quarter of 2024 was highlighted by important progress in the development of EB-003, our neuroplastogenic molecule that is...

Red Light Holland Corp. (CSE:TRIP) (FSE: 4YX) (OTCQB:TRUFF) announced its financial and operational results on Thursday for the first quarter of fiscal 2025, three months ending June 30, 2024. The Ontario-based company with a focus on the production and sale of functional mushrooms and mushroom...

Red Light Holland Corp. (CSE:TRIP) (OTCQB:TRUFF) reported its financial results Monday for the year ended March 31, 2024, revealing annual revenue of CA$4.7 million ($3.4 million), up by 20.3% from CA$3.9 million in the prior year. The Ontario-based producer of psilocybin truffles, functional...

Psychedelics-focused mental health care company Numinus Wellness Inc. (TSX:NUMI) (OTCQX:NUMIF), announced its third quarter financial results on Thursday for the three months ended May 31, 2024. "In the third quarter of 2024, we continued to make progress on our program to transition Numinus to an...

Psychedelics-focused mental health company Novamind Inc. (CSE:NM) (OTCQB: NVMDF) (FSE: HN2) reported its financial results for the three and six months ended December 31, 2021. “We’re pleased to report record high revenue this quarter driven by continued revenue growth from existing and...

Psychedelics-focused mental health care company Numinus Wellness Inc. (TSXV: NUMI) (OTCQX: NUMIF) announced its fiscal fourth quarter and full-year results Thursday for the periods ended August 31, 2021, with quarterly revenue of CA$500,000 ($394,153) up by 81% from...